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SUMMARY 
Eighty-nine depressed outpatients were studied by clinical criteria, Research Diagnos- 
tic Criteria (RDC), and the dexamethasone suppression test (DST) of neuroendocrine 
regulation. A simple outpatient version of the DST, requiring only one blood sample, 
correctly identified 40% of patients diagnosed clinically as endogenous depression (ED), 
with a specificity of 98% and a diagnostic confidence of 95%. Differences in age, sex, or 
severity of symptoms between endogenous and non-endogenous depressives did not 
account for these results. By comparison, the diagnostic performance of the DST was 
weaker for the RDC categories Major Depressive Disorder (MDD) and primary MDD. 
These were less selective and more heterogeneous than the clinical category ED. The 
clinical diagnoses of ED were supported in 98% of cases by the RDC, but 22% of RDC 
endogenous MDD diagnoses were not supported by the clinical diagnoses. Abnormal 
DST results were found only in patients with both the clinical diagnosis of ED and the 
RDC diagnosis of endogenous MDD. Patients with definite endogenous MDD had a 
significantly higher frequency of abnormal DST results (42%) than those with probable 
endogenous MDD (14%), or those with other RDC diagnoses (3%). A significant associa- 
tion was found between positive DST results and a positive family history of depression. 
These results support other evidence for use of a positive DST result as an external 
validating criterion for ED. The category MDD contained all cases diagnosed clinically as 
ED, but was diluted by cases diagnosed clinically as non-endogenous depression who had 
no neuroendocrine diturbance. The results also confirmed that the endogenous/non- 
endogenous and primary/secondary classifications of depression are not identical. 
We conclude: (1) that the DST can be used in the differential diagnosis of depressed 
outpatients as well as inpatients; (2) that the RDC category primary MDD and the 
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Washington University category primary depression are more heterogeneous and probably 
less valid than the clinical category ED; (3) that the RDC for endogenous MDD have only 
moderate validity; (4) that RDC diagnoses cannot substitute for careful clinical diagnoses 
in research studies, (5) that the best use of the RDC is to support clinical diagnoses, but 
not to generate diagnoses independently as a free-standing system; (6) that the concept of 
endogenous or endogenomorphic depression has validity and should be retained in 
research studies of depression. 
-- 
INTRODUCTION 
The most persistent issue in the long history of debate about the nosology 
of depression has been to discriminate illnesses with a presumed biological 
basis from those which are related primarily to psychological or social 
factors. The former group are frequently termed endogenous, endogeno- 
morphic, melancholic, autonomous or vital depressions in various classifica- 
tory systems, whereas the latter group tend to be described as reactive, 
neurotic or characterological depressions. The differential diagnosis of 
patients with depressed mood has until recently been based on clinical 
information alone, without the assistance of laboratory tests commonly 
used in other areas of medicine, and it is obvious from the current state of 
the field that no clinical system of classification has gained a general con- 
sensus. Furthermore, some current nosologic proposals in the United States, 
such as the Washington University criteria (Feighner et al. 1972), have 
adopted an ‘agnostic’, atheoretical approach which avoids the issue of 
endogenous depression altogether (Woodruff et al. 1974). 
In clinical practice disagreements about whether patients have endogenous 
or non-endogenous depression do not arise with typical cases but with 
patients who may have only mild endogenous depression (Watts 1957), or a 
mixture of both endogenous and ‘neurotic’ features. As Kendell (1976) 
emphasized recently , ‘the differences - in symptomatology, premorbid 
personality, treatment response, and lifetime course -between the two 
extremes are too extensive to be regarded merely as differences in severity 
and chronicity’. The real problem is to define an agreed boundary between 
them, and the various clinical checklist approaches to defining this bound- 
ary, such as the Newcastle Index (Carney et al. 1965) or the Research Diag- 
nostic Criteria (RDC) (Spitzer et al. 1977) are not generally accepted 
because they lack operational validity in the hands of several investigators 
(McConaghy et al. 1967; Kendell 1968; Nelson et al. 1978; Feinberg et al. 
1979). The Newcastle Index relies on a discriminant function which con- 
trasts endogenous with neurotic features, and to a certain extent it implies 
that patients with endogenous depression will lack neurotic or character- 
ologic symptoms. The RDC simply require the presence of at least 4 of 11 
classical endogenous symptoms for a ‘probable’ diagnosis and 6 symptoms 
for a ‘definite’ diagnosis of endogenous Major Depressive Disorder. Both 
approaches suffer from the problem recognised long ago by Gillespie (1929), 
namely, that clinical features alone are not ‘going to serve as a touchstone 
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for diagnosis, or prognosis, or as a therapeutic indication’. Even more 
importantly, both schemes pay no attention to certain clinical features that 
are usually weighted highly by clinicians, such as family history, bipolar 
course, and (in the case of the RDC) previous episodes. 
A laboratory procedure to assist in identifying the type of depression 
would clearly have wide clinical and research application, and several promis- 
ind advances in this area have appeared recently (Carroll 1980). Four years 
ago Carroll et al. (1976a,b) reported that the dexamethasone suppression 
test (DST) of neuroendocrine regulation correctly identified almost 50% of 
inpatients with endogenous depression at a high level of confidence. They 
also demonstrated that, in principle, a simplified version of the inpatient 
DST could be used for the diagnosis of depressed outpatients (Carroll and 
Curtis 1976). This report describes a confirmation of that prediction and 
compares several current nosologic proposals with the results obtained by 
the DST. 
PATIENTS AND METHODS 
We evaluated eighty-nine outpatients presenting consecutively to the 
Clinical Studies Unit (CSU) who received a clinical diagnosis of either endog- 
enous depression (47 patients) or non-endogenous depression (42 patients). 
Each patient was seen by a psychiatrist for a standard clinical assessment 
which usually included an interview with a close relative. Each completed 
a structured psychiatric interview, the Schedule for Affective Disorders and 
Schizophrenia (SADS) (Spitzer and Endicott 1978), which was administered 
by a trained social worker, research assistant or psychiatrist. Other sources of 
information included in the diagnostic evaluation were the patient’s previous 
psychiatric history, family history and past hospital records. The psychiatrist 
and the SADS interviewer then met for a diagnostic conference where items 
of information were cross-checked before consensus diagnoses were reached. 
Diagnoses were recorded as (1) clinical diagnosis and (2) RDC diagnosis. 
Most patients were rated for the severity of depressive symptoms by the 
Hamilton rating scale (Hamilton 1960) and by the Carroll self-rating scale 
(Feinberg et al. 1979). The latter is a new self-rating instrument designed to 
match closely the items contained in the clinician-rated Hamilton scale 
(Carroll et al. 19.73). 
The clinical features employed in the CSU for the diagnosis of endog- 
enous depression are listed in Table 1. Rather than adopt a fixed number of 
features as a diagnostic criterion we require that the illness should be 
perceived by the psychiatrist as consistent with- the syndrome ordinarily 
recognized as endogenous depression or melancholia. This requirement of 
‘pattern recognition’ by the psychiatrist is a well recognized element in the 
performance of skilled diagnosticians (Dudley 1968). At the same time, of 
course, variations in this skill are also a major source of diagnostic disagree- 
ments among clinicians. As will be shown, however, our clinical diagnoses of 
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TABLE 1 
Diagnostic features of endogenous depression 
Major 
History of mania, hypomania or endogenous depression 
Definite family history 
Severe agitation or retardation 
Depressive psychosis 
Pervasive anhedonia 
Definite pathological guilt 
Minor 
Depressed or dysphoric mood 
Middle or delayed insomnia 
Loss of appetite or weight 
Retardation or agitation 
Unrealistic self-reproach 
Anhedonia, not pervasive (includes decreased sex drive) 
Lack of reactivity 
Distinct quality of mood 
Diurnal variation 
Age at onset over 40 (unless bipolar) 
Duration more than 1 month and less than 1 year 
Response to previous treatments 
endogenous depression were supported by the RDC in 46 of 47 cases (98%). 
In making the diagnoses of endogenous depression we did not necessarily 
give negative weight to features such as lack of adequate personality, appar- 
ent psychogenesis, or anxiety, which are weighted negatively by the New- 
castle Index. Rather, we regard such ‘neurotic’ features as belonging to an 
independent clinical dimension, in keeping with Kiloh et al. (1972), Klein 
(1974) and Akiskal et al. (1977, 1979, 1980). The clinical features in Table 
1 are quite similar to those listed by Shopsin et al. (1976). They also include 
all the RDC items for the endogenous subtype of Major Depressive Disorder 
(MDD). 
The diagnoses of non-endogenous depression were based not only on the 
absence of endogenous features but also on the clinical assessment of the ill- 
ness as a whole. The 42 non-endogenous cases all presented with a major 
complaint of dysphoric mood and other associated symptoms. In 13 of the 
42 cases some RDC endogenous features were present, sufficient to warrant 
an RDC diagnosis of probable or definite endogenous MDD, if the RDC 
were used simply as a checklist. Despite the suggestion of an endogenous 
functional shift, however, the psychiatrists did not perceive these illnesses as 
consistent with endogenous depression. The most frequent reasons for the 
disagreement of our clinical and RDC diagnoses of these patients were that, 
although they satisfied the literal operational RDC for certain endogenous 
items (such as anhedonia, self-reproach, psychomotor retardation or distinct 
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quality of mood), their presentations of these features were felt to be 
unreliable and/or unconvincing. At the same time it should be noted that the 
diagnoses of non-endogenous depression were not based on personality type, 
manipulative, dependent or histrionic features, understandable psychological 
precipitants, or inferred unconscious conflicts. 
Patients in whom a pre-existing psychiatric disorder was diagnosed (before 
the onset of the current depression) were classified as endogenous or non- 
endogenous by the psychiatrists on the basis of their current clinical profiles, 
without reference to their previous character disorders, neuroses, or alcohol 
and drug abuse. This decision is consistent with the position of the Washing- 
ton University group that the endogenous/non-endogenous and primary/ 
secondary classifications are independent of each other (Woodruff et al. 
1974). Although diagnoses according to the Washington University criteria 
are not presented as such in the Results, it should be noted that all patients 
who met the RDC for MDD also met the Washington University criteria for 
depression. 
Patients were excluded from this study if they had a previous or current 
diagnosis of schizophrenia, drug-related psychosis or organic brain disease. 
Patients taking certain drugs or suffering from medical conditions known 
to affect the dexamethasone suppression test also were excluded (see Carroll 
1980). Over 80% of the patients were completely drug-free for at least 
7 days before the DST. 
A simplified version of the dexamethasone suppression test was given 
before treatment began. The patients took an oral dose of 1 mg dexa- 
methasone tablets at 11:30 p.m. and came to the hospital for a single blood 
sample for plasma cortisol at 4 p.m. the next day. Except for the visit to the 
hospital they followed their usual schedule of work or activity on the day of 
the test. They also collected a 24-h urine sample from the time of dexameth- 
asone administration. The results of urinary free cortisol measurements 
added very little to the information given by the plasma cortisol results, and 
have been reported in detail elsewhere (Carroll et al. 1980a). The criterion of 
an abnormal DST response was a plasma cortisol level greater than 6 pg/dl 
at 4 p.m. post-dexamethasone. The test performance was evaluated with the 
calculations of sensitivity, specificity, and predictive value (diagnostic con- 
fidence) as defined by Vecchio (1966) and Galen and Gambino (1975). 
Plasma cortisol was measured by the competitive protein binding method of 
Murphy (1967) with minor modifications as described by Carroll et al. 
(197613). The laboratory samples were assayed without knowledge of the 
clinical diagnosis, and the results were not released to the clinicians until the 
diagnostic evaluations were completed. 
RESULTS 
Clinical diagnoses, age, sex, severity 
Endogenous depression was diagnosed in 47 patients, of whom 29 were 
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unipolar and 18 bipolar. Twenty of the unipolar patients were experiencing 
at least their second episode of endogenous depression, while 9 were seen in 
their first episode. Eight bipolar patients had a past history of mania, while 
10 had a history of hypomania. Non-endogenous depression was diagnosed 
in 42 patients. The majority (32) received a clinical diagnosis of neurotic 
depressives (t = 2.65, P < 0.01). The two groups did not differ with respect 
on a character disorder (5), obsessive compulsive neurosis (4) or anxiety 
neurosis (1). 
Seventy percent of the endogenous depressives were female, as were 60% 
of the non-endogenous depressives. The mean age of the 47 endogenous 
depressives was 40.9 yr, compared with 32.7 yr for the 42 non-endogenous 
depressives (t = 2.65, P < 0.01). The two groups did not differ with respect 
to the rated severity of depressive symptoms. The mean Hamilton rating 
scores were 18.2 for the endogenous cases and 16.2 for the non-endogenous 
cases. The mean Carroll self-rating scores were 23.4 and 23.5, respectively. 
Hamilton ratings were available for 74% of all patients, and Carroll ratings 
for 81% of all patients. These subgroups with available ratings did not differ 
from the total group with respect to age, sex ratios, or frequency of abnor- 
mal DST results. 
RDC diagnoses 
The RDC diagnoses of the endogenous and non-endogenous cases are 
given in Tables 2 and 3, respectively. An RDC diagnosis of probable or 
definite endogenous Major Depressive Disorder was recorded in 46 of the 47 
endogenous cases (98%). In 43 endogenous cases the depression was primary 
according to the RDC, while in 4 cases it was secondary to obsessive compul- 
sive disorder (2), drug use disorder (1) or a significant medical disorder 
(advanced loss of vision due to diabetic retinopathy) (1). 
Twenty-five of the 42 non-endogenous cases (60%) met the RDC for 
Major Depressive Disorder and 13 (31%) also qualified for the endogenous 
RDC subtype (definite or probable). Most of these 25 patients diagnosed 
as MDD by the RDC were primary cases (19 of 25, or 76%). Six cases were 
secondary to obsessive compulsive disorder (l), phobic disorder (l), alcohol- 
TABLE 2 
RDC diagnoses of 47 cases diagnosed clinically as endogenous depression 
Major depressive disorder (MDD) 47 
endogenous (definite) 32 
endogenous (probable) 14 
non-endogenous 1 
Primary MDD 43 
Secondary MDD 4 
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TABLE 3 
RDC diagnoses of 42 cases diagnosed clinically as non-endogenous depression 






25 Minor depressive disorder 13 
6 
7 
12 Other a 4 
obsessive compulsive disorder 1 
generalized anxiety disorder 1 
19 labile personality disorder 1 
other psychiatric disorder 1 
6 
a All with dysphoric mood, 
km (l), drug use disorder (1) or a combination of alcoholism and drug use 
disorder (2). Thirteen non-endogenous cases received the RDC diagnosis of 
minor depressive disorder, while miscellaneous other RDC diagnoses were 
recorded in 4 cases. 
Comparison of clinical and RDC diagnoses 
(1) Major depressive disorder 
Among the total group of 89 patients the clinical diagnosis of endogenous 
depression was made only 47 times, while the RDC diagnosis of MDD was 
found appropriate much more often (72 cases). These results suggest that 
patients diagnosed as having Major Depressive Disorder by the RDC (or 
depression by the Washington University criteria) are likely to be a distinctly 
heterogeneous group when viewed from other clinical perspectives, as was 
emphasized also by Nelson et al. (1978) in their study of inpatients. Even 
the category primary MDD was diagnosed in 62 cases by the RDC and, as 
predicted by Woodruff et al. (1974), a large proportion of these cases (31%) 
were regarded as non-endogenous by the clinicians. These findings thus con- 
firm that the endogenous/non-endogenous and primary/secondary classifica- 
tions are not identical. Of the 47 cases diagnosed clinically as endogenous, 
43 (91%) were called primary MDD by the RDC, but so were 19 of the 42 
non-endogenous cases (45%). 
(2) Endogenous depression 
By contrast to the rather broad criteria for diagnosing MDD (or depres- 
sion in the Washington University system), the RDC subtype of endogenous 
MDD requires a more selective profile of symptoms. The comparison of the 
clinical and RDC diagnoses of endogenous depression is given in Table 4, 
which indicates that the two diagnostic systems agreed in 84% of the cases. 
Both probable and definite cases of endogenous MDD have been included in 
this comparison. This decision is in keeping with the fact that the clinical 
diagnoses also covered a range of diagnostic confidence from probable to 
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TABLE 4 







depressive disorder a 46 13 
Other 1 29 
Kappa 0.68. 
Diagnoses agree in 84% of cases. 
22% of RDC endogenous cases are not endogenous by clinical diagnosis. 
a Includes probable and definite cases. 
definite. As stated above, the clinical diagnoses of endogenous depression 
were confirmed by the RDC in all but one case. On the other hand, the RDC 
diagnosed endogenous MDD in 59 cases, compared to only 47 clinical diag- 
noses of endogenous depression. Thus, in 13 of 59 cases (22%) the RDC 
diagnosis of endogenous MDD was not supported by the clinical diagnosis. 
These results suggest that even the more restrictive RDC endogenous criteria 
are likely to yield a heterogeneous group of subjects for research studies. 
Dexamethasone suppression test 
Using the plasma cortisol criterion of 6 pg/dl, we found that 19 of the 47 
cases (40%) diagnosed clinically as endogenous depression had an abnormal 
DST result. By contrast, 41 of the 42 patients (98%) with non-endogenous 
depression had normal test results (Chi square 18.4, P< 0.0001). Based on 
these findings, the DST showed a sensitivity of 40%, with a specificity of 
98%. Thus the predictive value (diagnostic confidence) of an abnormal or 
positive DST result was 95%. That is, 19 of the 20 positive test results were 
true-positive for endogenous depression. On the other hand, the predictive 
value of a negative or normal DST result was only 59% for non-endogenous 
depression. The frequency of abnormal DST results in the various subgroups 
of patients with endogenous depression was: unipolar, first episode, 33%; 
recurrent unipolar 40%; bipolar with previous mania 63%; bipolar with 
previous hypomania 30%; all unipolar 38%; all bipolar 44%. There was no 
effect of sex on the DST results. Positive results were found in 36% of the 
males and 42% of the females with the clinical diagnosis endogenous depres- 
sion. Age also had no effect on the DST results. Among the 47 endogenous 
depressives the correlation of age with post-dexamethasone plasma cortisol 
was not significant (r = -0.14). By age cohorts the frequency of positive 
DST results was: 15-24 yr (n = 9) 78%; 25-34 yr (n = 13) 23%; 35-44 yr 
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(n= 5) 40%; 45-54 yr (n=lO) 40%; 55-64 yr (n=7) 29%; 65-84 yr 
(n = 3) 33%. Thus the difference in frequency of abnormal DST results 
between the endogenous and non-endogenous depressives was not explained 
by the significantly greater mean age of the endogenous group. 
In 41 of the 47 cases with endogenous depression we had adequate 
information about the family psychiatric history. Six cases were rejected 
because the patients were adoptees or because the sources of information 
were considered incomplete, based on blind chart review. The frequency of 
abnormal DST results was 43% in the remaining 41 cases, compared with 
40% in the total group of 47 endogenous depressives. Of the 41 informative 
cases, 30 (73%) had a definite or probable family history of depression. A 
positive DST result was found in 16 of these 30 cases (53%) with a positive 
family history, compared with 2 of 11 cases (18%) with a negative family 
history (Fisher exact test, P 0.047). This association of positive family 
history with positive DST result was seen both in unipolar cases (n = 25) and 
bipolar cases (n = 16). 
The positive DST results by RDC categories are shown in Table 5, which 
includes for comparison the clinical diagnoses as well. It can be seen that 
most of the RDC categories had a lower frequency of abnormal DST results 
than did the clinical endogenous depression group. All 20 patients with posi- 
tive DST results were found in the RDC category Major Depressive Disorder 
but the frequency of neuroendocrine disturbance was only 28% in this 
TABLE 5 
Frequency of abnormal DST results in diagnostic subgroups 















Primary endogenous MDD 
(definite and probable) 
Minor depressive disorder 
Other 
47 19 40 
42 1 2 
72 
62 19 31 
10 1 10 
59 19 32 
38 16 42 
21 












group. All 17 patients with RDC diagnoses other than MDD had negative 
DST results, as did 9 of the 10 cases with secondary MDD. The one positive 
DST result with secondary MDD occurred in a patient diagnosed clinically 
as endogenous depression, who also met endogenous RDC criteria, and who 
had a serious progressive medical condition (advanced visual failure due to 
diabetic retinopathy). No positive DST results were found in 9 patients with 
RDC diagnoses of MDD secondary to other psychiatric disorders. The RDC 
category definite endogenous MDD had a frequency of abnormal DST results 
slightly above the 40% figure found in the patients diagnosed clinically as 
endogenous depression. However, only 16 of the 20 positive tests were 
found in patients with definite endogenous MDD, compared with 19 in the 
group diagnosed clinically as endogenous depression. 
The frequency of abnormal DST results was distinctly lower in the 
patients with only a probable endogenous MDD diagnosis (14%) than in 
those with a definite diagnosis (42%) (Fisher exact test, P 0.026) and it was 
only 3% in those with neither definite nor probable endogenous MDD. Thus, 
if a high frequency of abnormal DST results is used as an external validating 
criterion, the RDC category definite endogenous MDD is significantly more 
valid than the category probable endogenous MDD, which in turn is more 
valid than the category not endogenous MDD. However, the category 
definite endogenous MDD is not more valid than the clinical category endog- 
enous depression. When the analysis above was restricted to the cases con- 
firmed as endogenous by the clinicians, then the frequency of abnormal DST 
results was: definite endogenous MDD 50%; probable endogenous MDD 
21%; not endogenous MDD 2%. 
The diagnostic performance of the DST for the major categories of inter- 
est is shown in Table 6. The overall performance was no better for any of 
the RDC categories than it was for the clinical category endogenous depres- 
sion. The RDC categories showed a lower sensitivity or predictive value for 
the DST. The lowering of sensitivity, as in the case of Major Depressive Dis- 
order, suggests that a more heterogeneous group of patients was selected by 
these criteria, although all the cases with neuroendocrine disturbance were 
identified. The lowering of specificity and predictive value, as in the case of 
definite endogenous MDD, suggests that this RDC diagnosis is more restric- 
tive than the clinical diagnosis of endogenous depression, by excluding more 
cases with neuroendocrine disturbance, even though the sensitivity was 
slightly higher at 42%. The well known balance or ‘trade-off’ between sensi- 
tivitiy and predictive value is illustrated clearly by these results (see’ Galen 
and Gambino 1975). 
When the disagreements between the clinical and RDC diagnoses of endog- 
enous depression (Table 4) were examined with respect to the DST results, 
the value of the DST as an independent validating criterion was reinforced. 
Table 7 shows the same data as Table 4, with the additional information of 
positive DST results in each of the four cells. The results in Table 7 indicate 




















































































































































































































































































Clinical and RDC diagnoses of endogenous depression in relation to DST results 
Number of abnormal DST results indicated in parentheses. __-- 










nosis of endogenous depression was also confirmed by the RDC. Thus, the 
neuroendocrine disturbance was strongly associated with the concordant 
diagnoses of endogenous depression. By contrast, there were no abnormal 
DST results among the 13 cases diagnosed as endogenous by the RDC, but 
about which the clinicians disagreed. Among the 59 patients diagnosed as 
endogenous MDD the distribution of abnormal DST results was significantly 
related to the clinical diagnosis (Fisher exact test, P< 0.003). For the 13 
cases about whom the clinicians disagreed with the RDC diagnosis, definite 
endogenous MDD was the RDC diagnosis in 6 patients, while probable 
endogenous MDD was the RDC diagnosis in 7 patients. Thus, the low rate of 
abnormal DST results in these 13 cases cannot be explained by their being 
only probable RDC endogenous cases. Only one abnormal DST result was 
found among the 29 patients diagnosed as non-endogenous by both the 
clinicians and the RDC. This low frequency (3%) is the same as we have 
found in non-patients (Carroll et al., unpublished observations) and appears 
to represent the background rate of nonspecific false-positive DST results 
in the general population. 
DISCUSSION 
The results of this outpatient study are consistent witch our previous 
studies of inpatients (Carroll et al. 1976b). The DST correctly identified 40% 
of the endogenous depressed patients at a confidence level of 95%. Our find- 
ings are supported by two recent studies of other investigators. Brown et al. 
(1979) found a sensitivity of 40% and a predictive value of 100% for the 
DST in a group of 20 inpatients with ‘primary endogenomorphic’ depression, 
compared with 29 inpatients with other diagnoses. Similarly, Yiannis et al. 
(1980) found a DST sensitivity of 43% and a predictive value of 100% in 16 
inpatients with ‘melancholic’ depression, compared with 22 other patients. 
By extending the work to outpatients in this study we have expanded the 
utility of this diagnostic test, since the majority of depressed patients are 
evaluated and treated in the outpatient setting. The high specificity of the 
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test could not be attributed to a lower severity of depressive symptoms in 
the non-endogenous cases, nor to age and sex differences. Rather, it was a 
function of the categorical distinction between endogenous and non-endog- 
enous depressions. 
The test procedure we used is simple enough to be implemented by any 
treatment facility, and most clinical laboratories can provide the plasma 
cortisol assays. The elimination of a urine collection (Carroll et al. 1980a) 
is an advantage both for the patients and for the laboratory, since we had 
found that great care was needed in the accurate measurement of low 
urinary free cortisol values. By using only a single post-dexamethasone 
blood sample some loss of sensitivity will occur. Based on our studies of 
inpatients (from whom post-dexamethasone blood samples were obtained 
at 8 a.m., 4 p.m. and 11:30 p.m.) we can state that 80% of the positive DST 
results will be detected by the 4 p.m. sample (Carroll et al., unpublished 
observations). We have opted for this 20% loss of sensitivity in the interest of 
developing a practical DST procedure for outpatient use. This decision is 
consistent with the fact that a positive DST result has a much higher predic- 
tive value or diagnostic significance (95%) than does a negative DST result 
(59%). Thus, a positive DST result is strongly associated with the diagnosis 
endogenous depression, whereas a negative DST result will not necessarily 
rule out this diagnosis. 
Our results indicate that the clinical category endogenous depression is 
not entirely congruent with the RDC category Major Depressive Disorder 
(or the Washington University category of depression). Even the RDC 
category primary MDD was not congruent with the clinical category endog- 
enous depression: 31% of the primary MDD cases were regarded as non- 
endogenous by clinical diagnosis. This finding is of course consistent with 
the explicit prediction of the Washington University group (Woodruff et al. 
1974), but it has not been demonstrated previously by the actual study of 
patients . 
The extent of agreement between clinical diagnoses, RDC diagnoses and 
Washington University diagnoses will not necessarily be consistent in differ- 
ent treatment settings. For example, Kupfer and associates found that 
virtually all inpatients with an RDC diagnosis of primary MDD also satisfied 
RDC endogenous criteria, whereas the majority of their secondary depres- 
sives did not (D. Kupfer, personal communication). For this study, however, 
the inclusion criteria specified that all patients should remain seriously 
depressed beyond a 2-week inpatient evaluation period. Non-endogenous 
primary depressives did not meet this criterion and thus were excluded from 
the sample. In an outpatient treatment setting, however, non-endogenous 
primary depressives are quite common, as we have shown. Similarly, 
Schlesser et al. (1979) reported DST results very similar to our own in 86 
inpatients with primary unipolar depression (by Washington University 
criteria) and, like ourselves, a very low rate of positive DST results among 
secondary depressives (G. Winokur, personal communication). It seems 
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likely, then, that there would be a high degree of congruence between 
‘primary depression’ and endogenous depression among inpatients at Iowa 
City. The logic of the two classificatory systems does not require a high 
degree of congruence, however, and the extent of agreement may be quite 
variable from one center to another. We would expect the greatest discor- 
dance between diagnoses of primary and endogenous depression in out- 
patient studies, in community surveys, and in studies of symptomatic 
volunteers who respond to newspaper advertisements for depression research 
studies. 
In attempting to compare the validity of various clinical and research 
classifications we have used the DST as an independent validating criterion. 
The rationale for this approach comes from several lines of evidence. An 
abnormal DST result has face validity in view of the high specificity and 
predictive value, confirmed now by several independent groups (Carroll et 
al. 1976b, 1980a; Brown et al. 1979; Schlesser et al. 1979; Yiannis et al. 
1980). The significant increments in sensitivity between the ‘absent’, 
‘probable’ and ‘definite’ endogenous MDD categories (Table 5) also are 
prima facie evidence for the use of the DST as an independent criterion of 
endogenous depression. Predictive validity is derived from observations that 
a conversion of abnormal DST responses to normal is associated with good 
prognosis after treatment, while failure of the DST response to convert to 
normal is associated with early relapse (Carroll 1972; Goldberg 1980; Greden 
et al. 1980a). Predictive validity is derived also from the findings that an 
abnormal DST response is associated with a significantly increased rate of 
response to antidepressant treatments (Brown et al. 1979; Greden et al., 
unpublished observations). Finally, construct validity for this approach is 
derived from several studies. DST responses return to normal with complete 
recovery, or with a switch into mania (Carroll 1972; Carroll et al. 1976a). A 
gradual improvement in DST responses occurs when the test is performed 
serially during a course of antidepressant drug treatment or electrotherapy 
(Carroll 1972; Carroll et al. 1976a; Dysken et al. 1979; Albala and Greden 
1980; M. Fink, personal communication). The association with a positive 
family history reported above is further evidence for construct validity of 
abnormal DST responses, and this association was found also by Schlesser 
et al. (1979). Construct validity also derives from studies which suggest 
that the neuroendocrine disturbance revealed by the DST indicates dysfunc- 
tion in the limbic system, the presumed site of pathology in the biological 
or endogenous depressions (Rubin and Mandell 1966; Carroll et al. 1968; 
Carroll 1972; Sachar et al. 1973). 
The obvious limitation of the DST as an independent validating criterion 
is that its sensitivity is only moderately high (about 45%). While this figure 
is comparable to that of some other diagnostic tests used in internal medi- 
cine (Carroll et al. 1980a), it is still clear that a consistently accurate 
laboratory diagnosis of endogenous depression will not be achieved by the 
DST alone. The heterogeneity of DST results among endogenous depressives 
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is so far unexplained. It may be related to genetic factors (alcoholism and 
sociopathy) (Schlesser et al. 1979) or to certain clinical features (Carroll et 
al. 1980b). Despite this limitation there is good evidence to support the 
validity of an abnormal DST response as an independent criterion for 
nosology. The prediction would be that the validity and homogeneity of a 
clinical diagnostic category are related to the frequency of abnormal DST 
results detected in that category. 
When our results were examined in light of this prediction they indicated 
that none of the RDC categories was superior to the clinical category 
endogenous depression. In particular, the RDC categories MDD and primary 
MDD had a lower frequency of positive DST results. The conclusion from 
these data is that the MDD and primary MDD categories are more heteroge- 
neous than the clinical category endogenous depression. Only the RDC cate- 
gory definite endogenous MDD was as powerful as the clinical endogenous 
depression category with respect to the frequency of abnormal DST results. 
In this case, however, there was a loss of specificity and predictive value. 
From our results we would suggest that the RDC for endogenous MDD 
can be misleading if they are used merely as a checklist to generate a diagno- 
sis among unselected depressed outpatients. Indeed, 22% of cases identified 
as endogenous MDD were considered non-endogenous by clinical diagnosis. 
Furthermore, the DST results strongly validated the clinical diagnoses rather 
than the RDC diagnoses of these cases. As described earlier, diagnostic dis- 
agreements arose with these patients because discriminating diagnosticians 
considered several of their apparently endogenous features to be unreliable, 
or unconvincing, or qualitatively different from those associated with 
definite endogenous depression. We stress, however, that these patients did 
satisfy the operational SADS-RDC criteria for endogenous MDD. We con- 
clude that the RDC, as presently formulated, do not identify endogenous 
depression with the same validity as experienced clinicians do. 
On the other hand, 98% of the clinical diagnoses of endogenous depres- 
sion were confirmed by the RDC (Table 4). The best use of diagnostic 
checklists like the RDC, therefore, may be to support clinical diagnoses 
rather than to generate diagnoses independently. Use of the RDC as a system 
of research documentation of clinical diagnoses can facilitate communication 
among clinical research centers, but there is no evidence available to support 
the notion that RDC diagnoses could substitute for discriminating clinical 
diagnoses in research studies. Our results indicate that there is an impressive 
concordance of neuroendocrine disturbance only with concordant clinical 
and RDC diagnoses of endogenous depression (Table 7). 
This need for clinical judgement in making research diagnoses was 
emphasized recently by another group of investigators (Carpenter et al. 
1980). They stressed that their research diagnostic system for schizophrenia 
cannot be used as ‘a free-standing system for identifying . . . patients or for 
differential diagnosis (but) rather . . . for ascertaining the confidence level of 
a diagnosis . . . and for defining a . . . cohort with reliable criteria under- 
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standable to other clinicians and investigators. It must be embedded in a 
broad clinical diagnostic evaluation’. When using the SADS and RDC instru- 
ments we have insisted (in the interest of reliability) on strict accordance 
with the operational definitions. Indeed, the very purpose of such instru- 
ments would only be vitiated if clinicians were free to impose the filter of 
clinical judgement on individual patients when making SADS-RDC evalua- 
tions. To the extent that this does occur (but is not acknowledged) in clini- 
cal research studies, statements that operationally strict ‘research’ diagnoses 
have been used are unrealistic. While disagreements between the diagnoses 
endogenous depression and MDD, or primary MDD, in the present study 
were largely definitional in origin, those between endogenous depression and 
endogenous MDD were related precisely to the point made by Carpenter et 
al. (1980). The RDC as a ‘free-standing’ system diluted the clinical category 
endogenous depression with cases that were not validated by the DST. 
A final conclusion from our results is that the concept of endogenous 
depression deserves to be retained in research studies. The ‘agnostic’ cate- 
gories of primary depression in the Washington University system and Major 
Depressive Disorder in the RDC are distinctly more heterogeneous not only 
from clinical perspectives but also with respect to neuroendocrine function. 
While the primary/secondary proposal of the Washington University group 
may possibly have some utility, it was unfortunately joined with a loose set 
of diagnostic criteria for depression. These criteria in turn were the direct 
precursors of those for the RDC category MDD. By avoiding the historically 
difficult problem of diagnosing endogenous depression it was hoped that 
these new categories would be more reliable. Our results indicate, however, 
that they are more heterogeneous and probably less valid than the clinical 
category endogenous depression. Their unquestioned use as research criteria 
might thus be viewed with serious reservations. Carey and Gottesman (1978) 
recently presented an extensive discussion of this problem of reliability -v- 
validity, and our results bear out several of their caveats about ‘reliable 
criteria’. Our work with the DST is one approach towards the development 
of independent laboratory criteria for subtypes of depression defined by 
pathophysiology in addition to clinical feat,ures. As these biological 
approaches to the nosology of depression are developed further (Carroll 
1980) the ‘old fashioned’ concept of endogerrous or endogenomorphic depres- 
sion is likely to be reinstated rather than discarded. 
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